Hyperhomocysteinemia and kidney diseases

Yun Feng Zhou; You Fei Guan

Hyperhomocysteinemia and kidney diseases

Yun Feng Zhou
, You Fei Guan

Shenzhen University
Dalian Medical University

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy level above 16 μmol/L which can result from abnormal Hcy metabolism. HHcy has been confirmed to be related to cardio-cerebrovascular disease, peripheral vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we summarize the correlation between HHcy and kidney diseases. Elucidating the role of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney diseases.

Original language	English
Pages (from-to)	607-611
Number of pages	5
Journal	Acta Physiologica Sinica
Volume	70
Issue number	6
State	Published - 25 Dec 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{40a8cdb93eec48e5b776bbe38c10a247,

title = "Hyperhomocysteinemia and kidney diseases",

abstract = "Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy level above 16 μmol/L which can result from abnormal Hcy metabolism. HHcy has been confirmed to be related to cardio-cerebrovascular disease, peripheral vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we summarize the correlation between HHcy and kidney diseases. Elucidating the role of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney diseases.",

author = "Zhou, \{Yun Feng\} and Guan, \{You Fei\}",

year = "2018",

month = dec,

day = "25",

language = "英语",

volume = "70",

pages = "607--611",

journal = "Acta Physiologica Sinica",

issn = "0371-0874",

publisher = "Editorial Office of Acta Physiologica Sinica",

number = "6",

}

TY - JOUR

T1 - Hyperhomocysteinemia and kidney diseases

AU - Zhou, Yun Feng

AU - Guan, You Fei

PY - 2018/12/25

Y1 - 2018/12/25

N2 - Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy level above 16 μmol/L which can result from abnormal Hcy metabolism. HHcy has been confirmed to be related to cardio-cerebrovascular disease, peripheral vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we summarize the correlation between HHcy and kidney diseases. Elucidating the role of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney diseases.

AB - Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy level above 16 μmol/L which can result from abnormal Hcy metabolism. HHcy has been confirmed to be related to cardio-cerebrovascular disease, peripheral vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we summarize the correlation between HHcy and kidney diseases. Elucidating the role of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney diseases.

UR - https://www.scopus.com/pages/publications/85058725090

M3 - 文献综述

C2 - 30560269

AN - SCOPUS:85058725090

SN - 0371-0874

VL - 70

SP - 607

EP - 611

JO - Acta Physiologica Sinica

JF - Acta Physiologica Sinica

IS - 6

ER -

Hyperhomocysteinemia and kidney diseases

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this